Loading...
XSHE
000590
Market cap391mUSD
Dec 05, Last price  
11.55CNY
1D
1.32%
1Q
-5.25%
Jan 2017
-41.22%
Name

Tus Pharmaceutical Group Co Ltd

Chart & Performance

D1W1MN
XSHE:000590 chart
P/E
P/S
8.06
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
1.73%
Revenues
343m
-15.18%
271,110,822286,824,832207,905,036236,573,558274,089,961311,624,913343,508,517363,420,444256,000,679203,122,000294,719,555317,410,504343,539,198185,811,015315,034,457275,090,121300,774,612350,528,110404,647,908343,208,128
Net income
-125m
L
4,290,0122,894,26120,517,35020,374,461047,153,71372,134,381137,606,3350022,372,28255,175,21519,173,756042,442,30822,722,39735,438,60318,109,85425,246,778-125,471,522
CFO
17m
P
55,959,294068,039,94934,885,63234,144,67784,978,22630,866,20619,746,0604,122,1590000654,23729,208,43651,480,57925,196,29654,473,687-28,394,71717,387,972
Dividend
Jun 21, 20130.2 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Tus-Pharmaceutical Group Co., Ltd. manufactures and sells traditional Chinese medicine and western medicine products. The company was formerly known as Tus-Guhan Group Corp.,Ltd. Tus-Pharmaceutical Group Co., Ltd. was founded in 1956 and is based in Hengyang, China.
IPO date
Jan 19, 1996
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT